In Vivo Biodistribution of No-Carrier-Added 6-F-18-Fluoro-3, 4-Dihydroxy-L-Phenylalanine (F-18-DOPA), Produced by a New Nucleophilic Substitution Approach, Compared with Carrier-Added F-18-DOPA, Prepared by Conventional Electrophilic Substitution

Willem-Jan Kuik, Ido P. Kema, Adrienne H. Brouwers, Rolf Zijlma, Kiel D. Neumann, Rudi A. J. O. Dierckx, Stephen G. DiMagno, Philip H. Elsinga^*

^*Corresponding author for this work

Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE)

Research output: Contribution to journal › Article › Academic › peer-review

60 Citations (Scopus)

Fingerprint

Dive into the research topics of 'In Vivo Biodistribution of No-Carrier-Added 6-F-18-Fluoro-3, 4-Dihydroxy-L-Phenylalanine (F-18-DOPA), Produced by a New Nucleophilic Substitution Approach, Compared with Carrier-Added F-18-DOPA, Prepared by Conventional Electrophilic Substitution'. Together they form a unique fingerprint.

In Vivo Biodistribution of No-Carrier-Added 6-F-18-Fluoro-3, 4-Dihydroxy-L-Phenylalanine (F-18-DOPA), Produced by a New Nucleophilic Substitution Approach, Compared with Carrier-Added F-18-DOPA, Prepared by Conventional Electrophilic Substitution

Fingerprint

Chemistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases